Landlocked developing countries (LLDCs) vs Pakistan: Percentage of bloodstream infection due to Escherichia coli resistant
Landlocked developing countries (LLDCs)
74.2%
in 2022
Pakistan
83.5%
in 2022
Landlocked developing countries (LLDCs) rank
3rd
Pakistan rank
1st
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Landlocked developing countries (LLDCs)
- Pakistan
How they compare
Pakistan currently reports 83.5% against 74.2% in Landlocked developing countries (LLDCs), a difference of 9.3%.
That makes Pakistan's figure about 1.1 times Landlocked developing countries (LLDCs)'s.
Across all 6 years both countries report, Pakistan has been ahead every year.
Landlocked developing countries (LLDCs) ranks 3rd and Pakistan ranks 1st of 16 groups.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 32.3% | 81.4% | 49.1% | Pakistan |
| 2020s | 73.7% | 83.7% | 10.0% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Landlocked developing countries (LLDCs) or Pakistan?
- Pakistan, at 83.5% against 74.2% in Landlocked developing countries (LLDCs) as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Landlocked developing countries (LLDCs) and Pakistan?
- 9.3%, with Pakistan ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Pakistan?
- 6 years are reported by both, from 2017 to 2022.
- How do Landlocked developing countries (LLDCs) and Pakistan rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Landlocked developing countries (LLDCs) ranks 3rd and Pakistan ranks 1st of 16 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.